Pursuant to Regulation 47 of SEBI (LODR) Regulations, 2015, please find enclosed herewith Newspaper publication regarding Meeting of Board of Directors of the Company scheduled to be held ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gennex Laboratories has informed BSE about newspaper publications (Business Standard and Saksham Telugu, dated August 5, 2025) giving notice of a Board Meeting scheduled for Thursday, August 14, 2025 at 4:00 PM at the company's corporate office in Hyderabad. The Board will consider and approve the Unaudited Standalone and Consolidated Financial Results for the Quarter Ended June 30, 2025 (Q1 FY26), along with the Limited Review Report of the Statutory Auditors. This filing is a regulatory compliance under SEBI LODR Regulation 47, and the financial results themselves are not yet declared.
This is a routine procedural filing with no direct impact on shareholders, but it signals that the company's Q1 FY26 earnings will be announced shortly after August 14, 2025. Investors should watch for the upcoming results declaration, which could move the stock depending on the numbers.